Related Experiment Video
Updated: Mar 24, 2026
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
Updates on the Molecular Pathology of Selected Ocular and Ocular Adnexal Tumors: Potential Targets for Future Therapy
Anna M Stagner1, Frederick A Jakobiec1
1a David G. Cogan Ophthalmic Pathology Laboratory, Massachusetts Eye and Ear Infirmary, and Department of Ophthalmology, Harvard Medical School , Boston , Massachusetts , USA.
Abstract:
Ophthalmic pathologic studies of retinoblastoma first definitively elucidated a genetic etiology for cancer three decades ago. Advances in DNA sequencing, protein expression profiling, and the exploration of epigenetics have since led to categorization of tumors and clinical prognostication based on genetic aberrancy. There are now many neoplasms that are defined by a characteristic genetic signature. In the past several years alone, much has been discovered in regard to the original tumor-suppressor gene initially defined in retinoblastoma as well as in other intraocular tumors such as medulloepithelioma. Our further understanding of ocular adnexal tumors that result in substantial morbidity and mortality, such as sebaceous carcinoma, has also benefited from a genetic approach. In this article, we review the clinicopathologic features of the foregoing three entities--retinoblastoma, medulloepithelioma, and sebaceous carcinoma--in order to highlight discoveries in their underlying abnormal molecular genetic functioning.
Insights
Retinoblastoma research pioneered understanding cancer genetics. Genetic analysis now defines many tumors, including intraocular and ocular adnexal neoplasms like medulloepithelioma and sebaceous carcinoma, improving prognostication.
Area of Science:
- Ophthalmology
- Oncology
- Genetics
Background:
- Retinoblastoma studies first identified a genetic cause for cancer.
- Advances in molecular biology have enabled tumor classification and prognostication based on genetic profiles.
- Many neoplasms are now defined by specific genetic signatures.
Purpose of the Study:
- To review the clinicopathologic features of retinoblastoma, medulloepithelioma, and sebaceous carcinoma.
- To highlight discoveries in the abnormal molecular genetic functioning of these ocular tumors.
- To underscore the impact of genetic approaches on understanding and managing these conditions.
Main Methods:
- Review of clinicopathologic features of retinoblastoma, medulloepithelioma, and sebaceous carcinoma.
- Analysis of genetic and molecular alterations in these tumor types.
- Integration of genetic findings with clinical prognostication.
Main Results:
- Retinoblastoma established the link between genetics and cancer etiology.
- Genetic sequencing and epigenetic studies have refined tumor categorization and prognosis.
- Specific genetic aberrations are now recognized as defining characteristics for various neoplasms.
Conclusions:
- Genetic studies have been pivotal in understanding ocular tumors.
- Molecular genetic functioning is key to the diagnosis and management of retinoblastoma, medulloepithelioma, and sebaceous carcinoma.
- Continued genetic research promises further advancements in ocular oncology.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:22Microbiome of the Eye
01:20The Retinoblastoma Gene
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:25Glaucoma: Overview